Loading...

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate)

Pricing & Availability
Regulatory Status
RUO
Other Names
4',6-Diamidino-2-Phenylindole, Dilactate
Ave. Rating
Submit a Review
Product Citations
publications
1_Ankita_Patil.jpg
Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 1_Ankita_Patil.jpg
    Methanol fixed superior cervical ganglion neurons were stained with anti-tubulin β3 (pink) and anti-TRIM46 (aqua), then stained with secondary antibodies, phalloidin (orange) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Ankita Patil from Drexel University.
  • 2_Kathleen-Ignatoski
    Frozen mouse intestine stained with purified anti-Ankyrin-B (green), E-Cadherin (red) and DAPI (blue) followed by anti-goat Alexa Fluor® 488 and anti-rabbit Alexa Fluor® 568. Image generously submitted to the 2017 Cell Life Imaging Competition by Kathleen Ignatoski from University of Michigan.
  • 3_KifLiakath.jpg
    Whole mount mouse tail epidermis was stained with purified anti-Keratin 14 (green, clone Poly19053), purified anti-Keratin 15 (orange, clone Poly18339) and DAPI (blue). Image generously submitted to the 2017 Cell Life Imaging Competition by Kif Liakath.
  • 4_DAPI_IF_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
  • 5_DAPI_080712
    Human cervical cancer cell line, HeLa, was fixed with 4% paraformaldehyde and stained with 300 nM DAPI.
See DAPI (4',6-Diamidino-2-Phenylindole, Dilactate) spectral data
Cat # Size Price Quantity Check Availability Save
422801 10 mg 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

DAPI (4',6-Diamidino-2-Phenylindole, Dilactate), a blue fluorescent nucleic acid stain, preferentially binds dsDNA and associates with the minor groove AT clusters. The molecular weight for DAPI is 457.5.  Association of DAPI with dsDNA increases fluorescence approximately 20-fold, with an emission maximum of 460 nm. The increase in fluorescence is believed to be due to displacement of water molecules from the minor groove and DAPI. DAPI can also bind RNA and emits at a longer wavelength of 500 nm, with only a 20% increase in fluorescence.

DAPI is a popular nuclear stain for identification of cell cycle and specifically stains nuclei but not cytoplasm. The dilactate form is more water soluble compared to the dihydrochloride form.

DAPI can be excited by a UV laser, xenon, or a mercury-arc lamp. 

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Lyophilized
Preparation
To make 5 mg/ml (10.9 mM) solution, dissolve entire contents of vial in 2 ml of deionized water.
Storage & Handling
Store between 2°C and 8°C, protected from light. For long term storage, aliquot and store at -20°C.
Application

ICFC, ICC
Recommended Usage

This product can be used at 3 µM for flow cytometry and 300 nM for immunofluorescence.  It is recommended to titrate the dye for optimal performance. 

Excitation Laser
Ultraviolet Laser (355 nm)
Application Notes

Protocols for Counterstaining with DAPI:

Immunofluorescence Staining
Note: Cells may be fixed by method of choice, such as with 4% paraformaldehyde. DAPI staining is done after staining for other markers. Fixation and permeabilization of cells is not necessary to counterstain with DAPI.

1. Fix cells using method of choice.
2. Incubate the cells with phosphate buffered saline (PBS) for 15 minutes.
3. Dilute the DAPI solution (we recommend to 300 nM) with PBS. Remove excess PBS from the slide and cover with DAPI solution, making sure the cells are completely covered.
4. Incubate for up to 5 minutes. Rinse the slide several times to remove all free DAPI. It is recommended to use a mounting medium with antifade reagent to reduce fluorescence quenching. The slide is ready to view under the microscope with appropriate filters.


Nuclear Staining for Flow Cytometry
Note: Cells may be fixed with 4% paraformadehyde or absolute ethanol.

1. Fix cells with absolute ethanol or 4% paraformaldehyde.
2. Centrifuge, discard the supernatant, and add 5 ml of PBS, allowing cells to rehydrate for 15 minutes.
3. Dilute the DAPI to 3 µM (recommended) in staining buffer (such as BioLegend's FOXP3 Perm Buffer, Cat. No. 421402).
4. Centrifuge cell suspension from step 3 above, discard supernatant, and add 1 ml of DAPI solution; then incubate at room temperature for 15 minutes.
5. Analyze by flow cytometry using an instrument with appropriate lasers.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References
  1. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  2. Sodhi CP, et al. 2015. J Immunol. 194:4931. PubMed
Product Citations
  1. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  2. Davila ML, et al. 2022. iScience. 25:104426. PubMed
  3. DeDreu J, et al. 2021. Matrix Biol. 96:18. PubMed
  4. Duraiswamy J, et al. 2021. Cancer Cell. 39:1623. PubMed
  5. McCubbrey AL, et al. 2022. Cell Rep. 38:110222. PubMed
  6. Xiang J, et al. 2022. J Virol. 96:e0005722. PubMed
  7. Matta B, et al. 2022. Front Immunol. 13:951254. PubMed
  8. Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed
  9. Reemst K, et al. 2022. Transl Psychiatry. 12:507. PubMed
  10. Kaneko K, et al. 2022. Cancers (Basel). 14: . PubMed
  11. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  12. Sountoulidis A, et al. 2023. Nat Cell Biol. 25:351. PubMed
  13. Wang CQ, et al. 2023. Cells. 12: . PubMed
  14. Jeon EY, et al. 2023. Bioeng Transl Med. 8:e10362. PubMed
  15. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  16. Aru B, et al. 2023. Balkan Med J. 40:117. PubMed
  17. González-Terán B, et al. 2022. Cell. 185:794. PubMed
  18. Grubwieser P, et al. 2022. Front Cell Infect Microbiol. 12:875543. PubMed
  19. Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed
  20. Michalek S, et al. 2022. EMBO Rep. 23:e54195. PubMed
  21. Cherkaoui S, et al. 2022. Mol Syst Biol. 18:e11033. PubMed
  22. Chang L, et al. 2023. Life Sci Alliance. 6:. PubMed
  23. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  24. Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed
  25. Flinn MA, et al. 2023. Front Cardiovasc Med. 10:1142612. PubMed
  26. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  27. Huber M, et al. 2023. Nat Commun. 14:2143. PubMed
  28. Kerkering J, et al. 2023. J Clin Invest. . PubMed
  29. Basta MD, et al. 2023. iScience. 26:106570. PubMed
  30. Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed
  31. Gómez-Pinedo U, et al. 2023. Cells. 12:. PubMed
  32. Hoover MY, et al. 2023. Nat Protoc. . PubMed
  33. Sountoulidis A, et al. 2020. PLoS Biol. 18:e3000675. PubMed
  34. Mester B, et al. 2015. PLoS One. 10: e0140432. PubMed
  35. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  36. Velilla J, et al. 2019. Neurol Genet. 5:e312. PubMed
  37. Jiao Q, et al. 2017. Clin Exp Immunol. 188:420. PubMed
  38. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  39. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  40. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  41. Wilson K, et al. 2016. Cell Death Dis. 7: e2197. PubMed
  42. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  43. Anguiano T, et al. 2020. Toxicol Sci. 177:494. PubMed
  44. Afshar Y, et al. 2021. Nat Commun. 12:4408. PubMed
  45. Goodnough LH, et al. 2022. Front Endocrinol (Lausanne). 13:924927. PubMed
  46. Nguyen DT, et al. 2022. Cells. 11:. PubMed
  47. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  48. Gamboa CM, et al. 2021. STAR Protoc. 100345:2. PubMed
  49. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  50. Elias A, et al. 2016. Sci Rep. 6: 24971. PubMed
  51. Miedema A, et al. 2022. Acta Neuropathol Commun. 10:8. PubMed
  52. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  53. Valkov N, et al. 2021. Life Sci Alliance. 4:. PubMed
  54. Bannard O, et al. 2016. J Exp Med. 13: 993 - 1009. PubMed
  55. Sumitomo Y, et al. 2016. Blood. 128: 1614 - 1624. PubMed
  56. Paris AJ, et al. 2020. Nat Cell Biol. 1.747916667. PubMed
  57. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  58. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  59. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  60. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  61. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  62. Alexander MS, et al. 2021. Muscle Nerve. 63:928. PubMed
  63. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  64. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  65. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  66. DeDreu J, et al. 2020. FASEB J. 34:9316. PubMed
  67. Allam O, et al. 2018. PLoS One. 13:e0194185. PubMed
  68. Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
  69. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  70. Koh P, et al. 2016. Sci Data. 3:160109. PubMed
  71. Sodhi C, et al. 2015. J Immunol. 194:4931. PubMed
  72. Kanda K, et al. 2018. JCI Insight. 3:e91316. PubMed
  73. Fujiwara H, et al. 2021. Nat Immunol. 22:1440. PubMed
  74. Ravi A, et al. 2021. Dev Cell. 56:1661. PubMed
  75. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  76. Poulos M, et al. 2016. Nat Commun. 7:13829. PubMed
  77. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  78. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  79. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  80. Hendricks A, et al. 2020. Cancers (Basel). 12:00. PubMed
  81. Aronovich A, et al. 2021. J Invest Dermatol. 141:619. PubMed
  82. Teo YV, et al. 2019. Cell Rep. 27:997. PubMed
  83. Hayama Y, et al. 2018. J Immunol. 200:3790. PubMed
  84. Fredriksson-Lidman K, et al. 2017. PLoS One. 10.1371/journal.pone.0185509. PubMed
  85. Wennerberg E, et al. 2022. Sci Transl Med. 14:eabe8195. PubMed
  86. Kumar A, et al. 2021. STAR Protoc. 2:100874. PubMed
  87. Faisal S, et al. 2016. Sci Rep. 6:39530. PubMed
  88. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  89. Thompson M, et al. 2015. J Immunol. 195: 5637 - 5647. PubMed
  90. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  91. Pagan JD, et al. 2018. Cell. 172:564. PubMed
  92. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  93. Zhu M, et al. 2021. Eneuro. 8:. PubMed
  94. Flores-Pliego A, et al. 2021. Cells. 10:. PubMed
  95. Shani O, et al. 2021. Elife. 10: . PubMed
  96. Moser J, et al. 2016. Sci Rep. 6:35387. PubMed
  97. Mould KJ, et al. 2019. JCI Insight. 4:00. PubMed
  98. Heath O, et al. 2021. Cancer Immunol Res. 9:665. PubMed
  99. Dasinger JH, et al. 2021. Pregnancy Hypertens. 24:126. PubMed
  100. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  101. Correa A, et al. 2015. PLoS One. 10: 0143391. PubMed
  102. Yanting C, et al. 2018. J Dairy Sci. 101:1601. PubMed
  103. Kurena B, et al. 2017. Front Immunol. 1.490972222. PubMed
  104. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  105. Aziz M, et al. 2017. J Immunol. 10.4049/jimmunol.1602056. PubMed
  106. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  107. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  108. Wang Y, et al. 2021. EMBO Mol Med. 13:e14089. PubMed
  109. Chiang M, et al. 2019. Cell Rep. 28:3212. PubMed
  110. Valdespino-Vázquez MY, et al. 2021. J Med Virol. 93:4480. PubMed
  111. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  112. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  113. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  114. Vergoni B, et al. 2016. Diabetes. 65: 3062 - 3074. PubMed
  115. Dent JR, et al. 2019. J Appl Physiol (1985). 127:1117. PubMed
  116. Schmidt A, et al. 2017. Toxicol Lett. 10.1016/j.toxlet.2017.08.008. PubMed
  117. Canals Hernaez D, et al. 2022. Front Oncol. 12:856424. PubMed
  118. Mascharak S, et al. 2022. Cell Stem Cell. 29:315. PubMed
  119. Rodriguez A, et al. 2021. Cell Stem Cell. 28:33. PubMed
  120. Pang J, et al. 2021. STAR Protoc. 2:100879. PubMed
  121. Haschak M, et al. 2021. Aging (Albany NY). 13:16938. PubMed
  122. Phan TS, et al. 2021. Sci Adv. 7:. PubMed
  123. Stancil IT, et al. 2021. Nat Commun. 12:4566. PubMed
  124. Margaroli C, et al. 2021. Cell Rep Med. :100242. PubMed
  125. Burns F, et al. 2015. Aquatic Toxicology. 164: 52-60. PubMed
  126. Stevens M, et al. 2016. Nat Biotechnol. 34:1161-1167. PubMed
  127. Shilts J, et al. 2021. Sci Rep. 0.745138889. PubMed
  128. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  129. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  130. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  131. Anisul M, et al. 2021. Elife. 10:. PubMed
  132. DeDreu J, et al. 2022. FASEB J. 36:e21995. PubMed
  133. Pelham-Webb B, et al. 2021. Mol Cell. 81:1732. PubMed
  134. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  135. Hassanein W, et al. 2017. Organogenesis. 13:16. PubMed
  136. Aimi F, et al. 2021. Mod Pathol. 34:1468. PubMed
  137. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  138. Karimzadeh A, et al. 2021. Front Cell Dev Biol. 9:734176. PubMed
  139. Reeves KM, et al. 2021. Clin Cancer Res. Online ahead of print. PubMed
  140. Chen HY, et al. 2020. J Immunol. 1158:204. PubMed
  141. Gosztyla C, et al. 2020. Tissue Eng Part C Methods. 26:67. PubMed
  142. Köhler VK, et al. 2020. Int J Mol Sci. 21:00. PubMed
  143. Solomonov I, et al. 2014. Sci Rep. 4:5987. PubMed
  144. Srijiwangsa P, et al. 2018. BMC Pharmacol Toxicol. 19:32. PubMed
  145. Ladd MR, et al. 2018. Tissue Eng Part C Methods. 24:331. PubMed
  146. Bennett AH, et al. 2018. PLoS Genet. 14:e1007226. PubMed
  147. Doorley L, et al. 2017. Immunobiology.. 10.1016/j.imbio.2017.08.002. PubMed
  148. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  149. Tominaga K, et al. 2022. iScience. 25:103667. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Antigen References

1. Langlois RG, et al. 1980. Chromosoma. 77:229.
2. Kubista M, et al. 1987. Biochemistry 26:4545.

Gene ID
NA
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account